Oncology
Showing page 7 of 11 pages of list content
-
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent but clinically inapparent in cancer patients under immune checkpoint therapy
This article's authors -
Neutralization breadth of SARS CoV-2 viral variants following primary series and booster SARS CoV-2 vaccines in patients with cancer
This article's authors -
Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients
This article's authors -
Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer
This article's authors -
Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients
This article's authors -
Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling
This article's authors -
Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer
This article's authors -
High Seroconversion Rates Amongst Black and Hispanics With Hematologic Malignancies after SARS-CoV-2 Vaccination
This article's authors -
COVID-19 Outcomes in Patients with Cancer: Findings from the University of California Health System Database
This article's authors -
Immunogenicity and Safety of the inactivated SARS-CoV-2 vaccine (BBIBP-CorV) in patients with malignancy
This article's authors